Brazil to become IFFIm donor, Italy increases funding
Brazil to become IFFIm donor, Italy increases funding
14 June 2011
Italy and Brazil have pledged US$ 37 million and US$ 20 million respectively to IFFIm to support GAVI's vaccination programmes.
Italy and Brazil have pledged US$ 37 million and US$ 20 million respectively to IFFIm to support GAVI's vaccination programmes.
London, 14 June 2011 - Italy and Brazil pledged US$ 57 million to IFFIm at the GAVI Alliance’s first pledging conference.
The funds IFFIm generates from the Italian and Brazilian pledges will be used by GAVI to purchase and deliver vaccines and strengthen health services in developing countries.
Statement of strong support
The two new commitments represent a strong statement of support for IFFIm. The pledges raise total contributions to IFFIm to US$ 6.3 billion over 23 years. The pledges break down as follows:
- Brazil: US$ 20 million. The pledge, once formalised, would make Brazil IFFIm’s 10th donor. Brazil has been at the forefront of several innovative finance initiatives in health care, and its contribution to IFFIm points to a significant trend of emerging nations becoming increasingly influential in international development. The pledge will be paid over a 20-year period.
- Italy: €25.5 million (US$ 37 million) to be paid over the next 15 years. Italy has been at the forefront of using IFFIm to support the GAVI Alliance, having pledged US$ 638 million to be paid over 20 years.
“These nations are showing strong leadership by driving the global health agenda forward,” said Alan Gillespie, Chair of the IFFIm Board of Directors.
Support from other donors
"These nations are showing strong leadership by driving the global health agenda forward," said Alan Gillespie, Chair of the IFFIm Board of Directors.
Other donor nations also expressed strong support for IFFIm at the GAVI pledging conference. The UK, for instance, pledged US$ 1.34 billion to GAVI and is exploring channelling a small proportion of its new pledge through IFFIm.
The UK Department for International Development noted that IFFIm is an extremely efficient and cost-effective mechanism that has a strong role to play in GAVI's future.
“GAVI has been a force for innovation with IFFIm, cost-effectively delivering additional funding for immunisation,” said Gunilla Carlsson, Sweden’s Minister for International Development Cooperation in its Ministry for Foreign Affairs. Sweden has pledged US$ 38 million to IFFIm over 15 years.
“We believe in innovative finance, and we believe in more creative ideas,” said José Luis Solano Gadea, Spain’s ambassador at large for Public-Private Partnership in its Global Health Ministry of Foreign Affairs and Cooperation. Spain has pledged US$ 240 million to be paid over a 20-year period.
“Fiscal sustainability of vaccines is crucial to the future success of GAVI,” said Ngozi Okonjo-Iweala, a managing director of the World Bank, which acts as financial adviser and treasury manager to IFFIm.
“We are happy to support GAVI in its innovative finance work.”
Italy and Brazil have pledged a combined total of US$ 57 million to an innovative financing initiative that converts the long-term pledges into immediate funds for children's vaccination programmes.
Unprecedented pledging conference
The pledges were part of yesterday's unprecedented pledging conference by the GAVI Alliance, which raised US$ 4.3 billion overall.
The GAVI Alliance will use funds generated from the Italian and Brazilian pledges to purchase and deliver vaccines and strengthen health services in developing countries.
Share this article
Restricted Access Library
The material in this Restricted Access Library is intended to be accessed only by persons with residence within the territory of a Member State of the European Union and is not intended to be viewed by any other persons. The material in this Restricted Access Library is provided by IFFIm for information purposes only and the materials contained herein were accurate only as of their respective dates. Certain information in the materials contained herein is not intended to be, and is not, current. IFFIm accepts no obligation to update any material contained herein.
Persons with residence outside the territory of a Member State of the European Union who have access to or consult any materials posted in this Restricted Access Library should refrain from any action in respect of the securities referred to in such materials and are otherwise required to comply with all applicable laws and regulations in their country of residence.
By clicking Access restricted content: DYNAMIC-LINK-TEXT I confirm that I have read and understood the foregoing and agree that I will be bound by the restrictions and conditions set forth on this page.
The materials in this Restricted Access Library are for distribution only to persons who are not a "retail client" within the meaning of section 761G of the Corporations Act 2001 of Australia and are also sophisticated investors, professional investors or other investors in respect of whom disclosure is not required under Part 6D.2 of the Corporations Act 2001 of Australia and, in all cases, in such circumstances as may be permitted by applicable law in any jurisdiction in which an investor may be located.
The materials in this Restricted Access Library and any documents linked from it are not for access or distribution in any jurisdiction where such access or distribution would be illegal. All of the securities referred to in this Restricted Access Library and in the linked documents have been sold and delivered. The information contained herein and therein does not constitute an offer for sale in the United States or in any other country. The securities described herein and therein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and may not be offered or sold in the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with any applicable state securities laws.
Each person accessing the Restricted Access Library confirms that they are a person who is entitled to do so under all applicable laws, regulations and directives in all applicable jurisdictions. Neither IFFIm nor any of their directors, employees, agents or advisers accepts any liability whatsoever for any loss (including, without limitation, any liability arising from any fault or negligence on the part of IFFIm or its respective directors, employees, agents or advisers) arising from access to Restricted Access Library by any person not entitled to do so.
Reflections on IFFIm: an interview with Rachel Turner
14 November 2024